(Q43055983)

English

SAHA and curcumin combinations co-enhance histone acetylation in human cancer cells but operate antagonistically in exerting cytotoxic effects

scientific article published in May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

SAHA and curcumin combinations co-enhance histone acetylation in human cancer cells but operate antagonistically in exerting cytotoxic effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

0 references

histone acetylation

1 reference

based on heuristic

inferred from title

author name string

Jin-Yan Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Na Lu

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Zheng Yan

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Nan Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Journal of Asian Natural Products Research

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

335-348

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Discovery and development of SAHA as an anticancer agent

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Rational combinations using HDAC inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Curcumin-induced histone hypoacetylation: the role of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

CombiTool--a new computer program for analyzing combination experiments with biologically active agents.

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Curcumin attenuates acrylamide-induced cytotoxicity and genotoxicity in HepG2 cells by ROS scavenging

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1080%2F10286021003730348

21 January 2018

Identifiers

10.1080/10286021003730348

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43055983&oldid=1978828348"